Brooks Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 217.47 million compared to INR 153.03 million a year ago. Revenue was INR 219.02 million compared to INR 153.95 million a year ago. Net loss was INR 38.79 million compared to INR 50.19 million a year ago. Basic loss per share from continuing operations was INR 1.51 compared to INR 2.03 a year ago. Diluted loss per share from continuing operations was INR 1.51 compared to INR 2.03 a year ago.
For the nine months, sales was INR 617.64 million compared to INR 505.08 million a year ago. Revenue was INR 620.66 million compared to INR 507.71 million a year ago. Net loss was INR 99.86 million compared to INR 166.02 million a year ago. Basic loss per share from continuing operations was INR 3.9 compared to INR 6.72 a year ago. Diluted loss per share from continuing operations was INR 3.9 compared to INR 6.72 a year ago.